Liu et al., 2013 - Google Patents
Disruption of Smad7 promotes ANG II-mediated renal inflammation and fibrosis via Sp1-TGF-β/Smad3-NF. κB-dependent mechanisms in miceLiu et al., 2013
View HTML- Document ID
- 13323625396986704883
- Author
- Liu G
- Li Y
- Huang X
- Wei L
- Chen H
- Shi Y
- Heuchel R
- Lan H
- Publication year
- Publication venue
- PloS one
External Links
Snippet
Smad7 is an inhibitory Smad and plays a protective role in obstructive and diabetic kidney disease. However, the role and mechanisms of Smad7 in hypertensive nephropathy remains unexplored. Thus, the aim of this study was to investigate the role and regulatory …
- 108010021883 Smad7 Protein 0 title abstract description 118
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Liu et al. | Disruption of Smad7 promotes ANG II-mediated renal inflammation and fibrosis via Sp1-TGF-β/Smad3-NF. κB-dependent mechanisms in mice | |
| Lu et al. | Circulating miR-103a-3p contributes to angiotensin II-induced renal inflammation and fibrosis via a SNRK/NF-κB/p65 regulatory axis | |
| Tang et al. | Neural transcription factor Pou4f1 promotes renal fibrosis via macrophage–myofibroblast transition | |
| Zhang et al. | LRNA9884, a novel smad3-dependent long noncoding RNA, promotes diabetic kidney injury in db/db mice via enhancing MCP-1–dependent renal inflammation | |
| Chung et al. | Smad7 suppresses renal fibrosis via altering expression of TGF-β/Smad3-regulated microRNAs | |
| Kim et al. | Polycomb-and methylation-independent roles of EZH2 as a transcription activator | |
| Huang et al. | FoxO1-mediated inhibition of STAT1 alleviates tubulointerstitial fibrosis and tubule apoptosis in diabetic kidney disease | |
| Jia et al. | Dysregulation of histone H3 lysine 27 trimethylation in transforming growth factor-β1–induced gene expression in mesangial cells and diabetic kidney | |
| Sun et al. | Novel lncRNA Erbb4-IR promotes diabetic kidney injury in db/db mice by targeting miR-29b | |
| Marangoni et al. | Adiponectin is an endogenous anti-fibrotic mediator and therapeutic target | |
| Wei et al. | miR-455-3p alleviates hepatic stellate cell activation and liver fibrosis by suppressing HSF1 expression | |
| Yuan et al. | Involvement of p300/CBP and epigenetic histone acetylation in TGF-β1-mediated gene transcription in mesangial cells | |
| Kimura et al. | Stable expression of HIF-1α in tubular epithelial cells promotes interstitial fibrosis | |
| Wu et al. | MicroRNA-27a induces mesangial cell injury by targeting of PPARγ and its in vivo knockdown prevents progression of diabetic nephropathy | |
| Chen et al. | MicroRNA-29b inhibits diabetic nephropathy in db/db mice | |
| de Kerckhove et al. | Targeting miR‐223 in neutrophils enhances the clearance of Staphylococcus aureus in infected wounds | |
| Walesky et al. | Hepatocyte-specific deletion of hepatocyte nuclear factor-4α in adult mice results in increased hepatocyte proliferation | |
| Villanueva et al. | Adipose subtype-selective recruitment of TLE3 or Prdm16 by PPARγ specifies lipid storage versus thermogenic gene programs | |
| Zhou et al. | Long noncoding RNA Arid2-IR is a novel therapeutic target for renal inflammation | |
| Nakagawa et al. | Malat1 is not an essential component of nuclear speckles in mice | |
| Reiniger et al. | Deletion of the receptor for advanced glycation end products reduces glomerulosclerosis and preserves renal function in the diabetic OVE26 mouse | |
| Boffa et al. | Regression of renal vascular fibrosis by endothelin receptor antagonism | |
| Zhao et al. | Chaihuang-Yishen granule inhibits diabetic kidney disease in rats through blocking TGF-β/Smad3 signaling | |
| Liu et al. | Smad7 inhibits AngII-mediated hypertensive nephropathy in a mouse model of hypertension | |
| Schuüller et al. | Forkhead transcription factor FoxM1 regulates mitotic entry and prevents spindle defects in cerebellar granule neuron precursors |